Avenue Therapeutics Inc

General ticker "ATXI" information:

  • Sector: Health Care
  • Industry: Pharmaceuticals
  • Capitalization: $3.0M

Avenue Therapeutics Inc does not follow the US Stock Market performance with the rate: -42.7%.

Estimated limits based on current volatility of 5.0%: low 1.71$, high 1.88$

Factors to consider:

  • Current price 75.0% below estimated low
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [7.21$, 29.66$]
  • 2024-12-30 to 2025-12-30 estimated range: [3.13$, 11.62$]

Financial Metrics affecting the ATXI estimates:

  • Negative: Non-GAAP EPS, $ of -95.49 <= 0.10
  • Negative: Operating profit margin, % of -100 <= 1.03
  • Negative: Operating cash flow per share per price, % of -84.67 <= 2.35
  • Negative: negative Net income
  • Negative: Investing cash flow per share, $ of -21.28 <= -3.48
  • Negative: Industry operating cash flow per share per price (median), % of -12.63 <= 3.85

Similar symbols

Short-term ATXI quotes

Long-term ATXI plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $3.74MM $8.04MM $14.54MM
Operating Income $-3.74MM $-8.04MM $-14.54MM
Non-Operating Income $0.01MM $4.44MM $4.05MM
Interest Expense $0.00MM $1.16MM $0.00MM
R&D Expense $1.25MM $2.70MM $10.36MM
Income(Loss) $-3.73MM $-3.60MM $-10.49MM
Taxes $0.00MM $0.00MM $-0.11MM
Profit(Loss) $-3.73MM $-3.60MM $-10.38MM
Stockholders Equity $3.45MM $3.90MM $1.58MM
Assets $3.96MM $6.84MM $1.85MM
Operating Cash Flow $-3.75MM $-7.60MM $-9.45MM
Capital expenditure $0.00MM $0.00MM $3.00MM
Investing Cash Flow $0.00MM $0.00MM $-3.00MM
Financing Cash Flow $4.38MM $10.54MM $7.53MM
Earnings Per Share* $-3.29 $-0.94 $-73.60

* EPS are Split Adjusted, recent splits may be reflected with a delay.